AR013114A1 - Fenoles y tiofenoles alquil-4-sililheterociclicos, utiles como agentes antioxidantes - Google Patents
Fenoles y tiofenoles alquil-4-sililheterociclicos, utiles como agentes antioxidantesInfo
- Publication number
- AR013114A1 AR013114A1 ARP980102977A ARP980102977A AR013114A1 AR 013114 A1 AR013114 A1 AR 013114A1 AR P980102977 A ARP980102977 A AR P980102977A AR P980102977 A ARP980102977 A AR P980102977A AR 013114 A1 AR013114 A1 AR 013114A1
- Authority
- AR
- Argentina
- Prior art keywords
- useful
- alkyl
- hydrogen
- sililheterociclicos
- thiophenols
- Prior art date
Links
- 239000003963 antioxidant agent Substances 0.000 title abstract 2
- 150000002989 phenols Chemical class 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 3
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 208000017667 Chronic Disease Diseases 0.000 abstract 1
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 abstract 1
- 102000015271 Intercellular Adhesion Molecule-1 Human genes 0.000 abstract 1
- 241000895680 Stylosanthes guianensis Species 0.000 abstract 1
- 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 abstract 1
- 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000006866 deterioration Effects 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 239000011368 organic material Substances 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- 238000005502 peroxidation Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
- C07F7/0814—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invencion proporciona compuestos de formula donde R es hidrogeno o -C(O)-(CH2)m-Q, donde Q es hidrogeno o -COOH y m es un numeroentero 1, 2, 3 o 4; R1, R5 y R6 son independientemente un grupo alquilo C1-6; R2, R3 y R4 son independientemente hidrogeno o un grupo alquilo C1-6; Z estio, oxi o un grupo metileno; A es un grupo alquileno C1-4; G1 y G2 son independientemente hidrogeno, alquilo C1-6 o C(O)-(CH2)n-CH3 y n es un numeroentero 0, 1 o 3, o una sal farmacéuticamente aceptable de los mismos, utiles para el tratamiento de la arterioesclerosis y de trastornos inflamatorioscronicos, para inhibir la expresion inducida por citokinas de VCAM-1 y/o ICAM-1, para inhibir la peroxidacion de LDL lípido, parareducir el colesterolplasmático y como aditivos químicos antioxidantes utiles para prevenir el deterioro oxidativo en materiales orgánicos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88162797A | 1997-06-24 | 1997-06-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR013114A1 true AR013114A1 (es) | 2000-12-13 |
Family
ID=25378856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980102977A AR013114A1 (es) | 1997-06-24 | 1998-06-22 | Fenoles y tiofenoles alquil-4-sililheterociclicos, utiles como agentes antioxidantes |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0998477B1 (es) |
| JP (1) | JP2002514226A (es) |
| KR (1) | KR20010014118A (es) |
| CN (1) | CN1147495C (es) |
| AR (1) | AR013114A1 (es) |
| AT (1) | ATE235498T1 (es) |
| AU (1) | AU731278B2 (es) |
| BR (1) | BR9810311A (es) |
| CA (1) | CA2293461C (es) |
| DE (1) | DE69812635T2 (es) |
| DK (1) | DK0998477T3 (es) |
| ES (1) | ES2190592T3 (es) |
| HK (1) | HK1027815A1 (es) |
| HU (1) | HUP0002775A3 (es) |
| IL (1) | IL133598A (es) |
| NO (1) | NO996395L (es) |
| NZ (1) | NZ501342A (es) |
| PT (1) | PT998477E (es) |
| SI (1) | SI0998477T1 (es) |
| TW (1) | TW517054B (es) |
| WO (1) | WO1998058938A1 (es) |
| ZA (1) | ZA985318B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1677804A1 (en) * | 2003-10-17 | 2006-07-12 | Amylin Pharmaceuticals, Inc. | Silyl phenols for promoting vascular health |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5155250A (en) * | 1990-07-05 | 1992-10-13 | Merrell Dow Pharmaceuticals Inc. | 2,6-di-alkyl-4-silyl-phenols as antiatheroscerotic agents |
| DE69434198T2 (de) * | 1993-12-10 | 2005-12-29 | Merrell Pharmaceuticals Inc., Cincinnati | Verfahren zur senkung des serumcholesterinspiegels mit 2,6-dialkyl-4 silyl-phenol derivaten |
-
1998
- 1998-05-21 DK DK98923681T patent/DK0998477T3/da active
- 1998-05-21 CA CA002293461A patent/CA2293461C/en not_active Expired - Fee Related
- 1998-05-21 IL IL13359898A patent/IL133598A/en not_active IP Right Cessation
- 1998-05-21 EP EP98923681A patent/EP0998477B1/en not_active Expired - Lifetime
- 1998-05-21 JP JP50443199A patent/JP2002514226A/ja active Pending
- 1998-05-21 CN CNB988065770A patent/CN1147495C/zh not_active Expired - Fee Related
- 1998-05-21 AT AT98923681T patent/ATE235498T1/de not_active IP Right Cessation
- 1998-05-21 BR BR9810311-3A patent/BR9810311A/pt not_active IP Right Cessation
- 1998-05-21 HU HU0002775A patent/HUP0002775A3/hu unknown
- 1998-05-21 AU AU75915/98A patent/AU731278B2/en not_active Ceased
- 1998-05-21 NZ NZ501342A patent/NZ501342A/en unknown
- 1998-05-21 DE DE69812635T patent/DE69812635T2/de not_active Expired - Fee Related
- 1998-05-21 KR KR19997012174A patent/KR20010014118A/ko active IP Right Grant
- 1998-05-21 ES ES98923681T patent/ES2190592T3/es not_active Expired - Lifetime
- 1998-05-21 PT PT98923681T patent/PT998477E/pt unknown
- 1998-05-21 WO PCT/US1998/010510 patent/WO1998058938A1/en active IP Right Grant
- 1998-05-21 SI SI9830429T patent/SI0998477T1/xx unknown
- 1998-06-18 ZA ZA985318A patent/ZA985318B/xx unknown
- 1998-06-19 TW TW087109867A patent/TW517054B/zh not_active IP Right Cessation
- 1998-06-22 AR ARP980102977A patent/AR013114A1/es not_active Application Discontinuation
-
1999
- 1999-12-22 NO NO996395A patent/NO996395L/no not_active Application Discontinuation
-
2000
- 2000-11-09 HK HK00107137A patent/HK1027815A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL133598A (en) | 2004-08-31 |
| DE69812635T2 (de) | 2003-10-23 |
| NZ501342A (en) | 2001-10-26 |
| TW517054B (en) | 2003-01-11 |
| HUP0002775A2 (hu) | 2001-05-28 |
| CA2293461A1 (en) | 1998-12-30 |
| EP0998477A1 (en) | 2000-05-10 |
| SI0998477T1 (en) | 2003-08-31 |
| IL133598A0 (en) | 2001-04-30 |
| EP0998477B1 (en) | 2003-03-26 |
| KR20010014118A (ko) | 2001-02-26 |
| ATE235498T1 (de) | 2003-04-15 |
| CA2293461C (en) | 2004-02-24 |
| ZA985318B (en) | 1999-01-11 |
| NO996395D0 (no) | 1999-12-22 |
| JP2002514226A (ja) | 2002-05-14 |
| DK0998477T3 (da) | 2003-07-21 |
| DE69812635D1 (de) | 2003-04-30 |
| BR9810311A (pt) | 2000-09-19 |
| ES2190592T3 (es) | 2003-08-01 |
| WO1998058938A1 (en) | 1998-12-30 |
| NO996395L (no) | 2000-02-23 |
| AU7591598A (en) | 1999-01-04 |
| HUP0002775A3 (en) | 2001-08-28 |
| PT998477E (pt) | 2003-07-31 |
| HK1027815A1 (en) | 2001-01-23 |
| CN1147495C (zh) | 2004-04-28 |
| CN1261367A (zh) | 2000-07-26 |
| AU731278B2 (en) | 2001-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2167716T3 (es) | Alquil-4-silil-fenoles y esteres de los mismos como agentes antiescleroticos. | |
| DE69705480D1 (de) | Verwendung von Oestrogenagonisten und -antagonisten zur Herstellung eines Medikaments zur Behandlung von Atherosklerose, unabhängig von Lipidsenkung | |
| PT896533E (pt) | Pentafluorobenzenosulfonamidas e analogos | |
| FI944418A0 (fi) | Kondensoituneet sykliset yhdisteet ja niiden käyttö | |
| ES2187660T3 (es) | Derivados de rapamicina. | |
| ES2017647B3 (es) | Nuevos tioeteres fenolicos como inhibidores de 5-lipoxigenasa. | |
| KR910007525A (ko) | 양모제 | |
| FI931202A (fi) | Antifungala cykliska peptider och foerfarande foer framstaellning av dessa | |
| FI943142A (fi) | Amidi- ja ureajohdannaiset, joilla on veren korkeita kolesteroliarvoja vastustava vaikutus, niiden valmistus ja terapeuttiset käytöt | |
| MY111178A (en) | Antitumor compositions and methods of treatment | |
| PT1178045E (pt) | Derivados de azaindole-etilamina como agentes de ligacao de receptores de acetilcolina nicotinicos | |
| SE9002206D0 (sv) | New compounds | |
| ES2191828T3 (es) | Fenoles y tiofenoles sustituidos utiles como agentes antioxidantes. | |
| MX9701819A (es) | Dihidrobenzofurano y compuestos relacionados, utiles como agentes antiiflamatorios. | |
| DK0623133T3 (da) | Substituerede aminoalkylforbindelser | |
| AR013114A1 (es) | Fenoles y tiofenoles alquil-4-sililheterociclicos, utiles como agentes antioxidantes | |
| DE69606337D1 (de) | Trizyklische Derivate, ihre Herstellung, ihre Verwendung zur Herstellung von optisch aktivem oder racemischem Colchizin, Thiocolchizin, dessen Analoge oder Derivate, und Intermediate | |
| DE69425970D1 (de) | Benzol-derivate, verwendbar für ischämische erkrankungen | |
| CA2256247A1 (fr) | Nouveaux composes heterocycliques, leur procede de praparation et les compositions pharmaceutiques qui les contiennent | |
| BR0007674A (pt) | Compostos, processo de preparação dos mesmos,medicamentos novos, e composição farmacêutica | |
| ES2164234T3 (es) | Fusacandinas antifungicas. | |
| BR8600203A (pt) | Processo para a preparacao de furazanos substituidos,composicoes praguicidas,processos para combater pragas e para a preparacao de composicoes | |
| ES2102774T3 (es) | Indolsulfonamidas como agentes antitumorales. | |
| EA200001157A2 (ru) | Новые замещенные производные (дигидро)бензоксазина и (дигидро)бензотиазина, способ их получения и содержащие их фармацевтические композиции | |
| JPS54122727A (en) | Fungicidal, antiseptic, anti-termitic agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |